Tian-yan Chi
No.103 Wenhua Road
Shenyang, 110016, China
Shenyang, 110016, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
The bexarotene derivative OAB-14 ameliorates cognitive decline in APP/PS1 transgenic mice by suppressing microglia-mediated neuroinflammation through the PPAR-γ pathway.
Journal: International immunopharmacology
Published: May 31, 2023
PINK1 overexpression prevents forskolin-induced tau hyperphosphorylation and oxidative stress in a rat model of Alzheimer's disease.
Journal: Acta pharmacologica Sinica
Published: July 13, 2021
Sigma-1 receptor activation alleviates blood-brain barrier dysfunction in vascular dementia mice.
Journal: Experimental neurology
Published: March 23, 2018
Xanthoceraside attenuates amyloid β peptide1-42-induced memory impairments by reducing neuroinflammatory responses in mice.
Journal: European journal of pharmacology
Published: July 03, 2017
Sigma-1 receptor in brain ischemia/reperfusion: Possible role in the NR2A-induced pathway to regulate brain-derived neurotrophic factor.
Journal: Journal of the neurological sciences
Published: September 17, 2016
The total triterpenoid saponins of Xanthoceras sorbifolia improve learning and memory impairments through against oxidative stress and synaptic damage.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: August 20, 2016
Sigma 1 receptor activation regulates brain-derived neurotrophic factor through NR2A-CaMKIV-TORC1 pathway to rescue the impairment of learning and memory induced by brain ischaemia/reperfusion.
Journal: Psychopharmacology
Published: June 26, 2014
Xanthoceraside rescues learning and memory deficits through attenuating beta-amyloid deposition and tau hyperphosphorylation in APP mice.
Journal: Neuroscience letters
Published: January 21, 2014
Xanthoceraside ameliorates mitochondrial dysfunction contributing to the improvement of learning and memory impairment in mice with intracerebroventricular injection of aβ1-42.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: December 13, 2013
Xanthoceraside inhibits pro-inflammatory cytokine expression in Aβ25-35/IFN-γ-stimulated microglia through the TLR2 receptor, MyD88, nuclear factor-κB, and mitogen-activated protein kinase signaling pathways.
Journal: Journal of pharmacological sciences
Published: August 23, 2013
Protective effect of xanthoceraside against β-amyloid-induced neurotoxicity in neuroblastoma SH-SY5Y cells.
Journal: Journal of Asian natural products research
Published: August 06, 2013
Xanthoceraside attenuates tau hyperphosphorylation and cognitive deficits in intracerebroventricular-streptozotocin injected rats.
Journal: Psychopharmacology
Published: December 03, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026